Cargando…

Myocarditis associated with immune checkpoint inhibitors: Practical considerations in diagnosis and management

Immune checkpoint inhibitors (ICI) have caused radical changes in the treatment scheme of many types of cancer in the past 10 years. ICIs are specific monoclonal antibodies that increase T-cell mediated immune response against cancer cells. Despite important advances in cancer treatment, uncontrolle...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gürdoğan, Muhammet, Yalta, Kenan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7460679/ https://www.ncbi.nlm.nih.gov/pubmed/32749254 http://dx.doi.org/10.14744/AnatolJCardiol.2020.79584

Ejemplares similares

Serum copeptin might improve risk stratification and management of aortic valve stenosis: a review of pathophysiological insights and practical implications
por: Yalta, Kenan, et al.
Publicado: (2019)

Management of high-degree atrioventricular block in the setting of cardiac sarcoidosis: a therapeutic controversy
por: Yalta, Kenan, et al.
Publicado: (2022)

Cancer Therapy-Related Pulmonary Hypertension: A Review of Mechanisms and Implications for Clinical Practice
por: Gürdoğan, Muhammet, et al.
Publicado: (2023)

Plasma Histone H4 and Its Implications in the Setting of Sepsis-related Myocardial Dysfunction
por: Yalta, Kenan, et al.
Publicado: (2020)

Multisystem Inflammatory Syndrome Versus Kawasaki Disease: Potential Differences in Pathogenetic and Clinical Implications
por: Yalta, Kenan, et al.
Publicado: (2023)

The Diagnosis and Management of Immune Checkpoint Inhibitor Cardiovascular Toxicity: Myocarditis and Beyond
por: Gilon, Dan, et al.
Publicado: (2022)

Atypical ‘de Winter pattern’ mimicking acute left main coronary artery lesion
por: Gurdogan, Muhammet, et al.
Publicado: (2020)

Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis
por: Jiménez-Alejandre, Rosa, et al.
Publicado: (2022)

A Liver Transplant Patient on Everolimus Treatment Presented with Acute Anterior Myocardial Infarction: Does the Type of Drug-eluting Stent Matter?
por: Gürdoğan, Muhammet, et al.
Publicado: (2020)

Asymptomatic Immune Checkpoint Inhibitor-associated Myocarditis
por: Tanabe, Junya, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor Myocarditis: Pathophysiological Characteristics, Diagnosis, and Treatment
por: Palaskas, Nicolas, et al.
Publicado: (2020)

Um Stent Mal Colocado na Artéria Septal Perfurante: Fístula Ventricular Direita, Hematoma do Septo Interventricular e Obstrução da Via de Saída do Ventrículo Direito
por: Demir, Melik, et al.
Publicado: (2023)

Systemic Inflammation in the Setting of Cardiac Myxomas: an Overview of Clinical and Practical Considerations
por: Yalta, Kenan, et al.
Publicado: (2021)

Clinical Characteristics and Outcomes in Immune Checkpoint Inhibitor Therapy-Associated Myocarditis
por: Thakker, Ravi A., et al.
Publicado: (2021)

Immune Checkpoint Inhibitor Associated Myocarditis and Cardiomyopathy: A Translational Review
por: Wang, Dong, et al.
Publicado: (2023)

Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
por: Zlotoff, Daniel A, et al.
Publicado: (2021)

Combination immunomodulation for immune-checkpoint-inhibitor-associated myocarditis
por: Johnson, Douglas B., et al.
Publicado: (2023)

Role of Cardiac Imaging in the Diagnosis of Immune Checkpoints Inhibitors Related Myocarditis
por: Ederhy, Stéphane, et al.
Publicado: (2021)

Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
por: Zou, Wenlu, et al.
Publicado: (2021)

Immune checkpoint inhibitor–associated myocarditis: Case reports and a review of the literature
por: Osinga, T. E., et al.
Publicado: (2022)

Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis
por: Doms, J., et al.
Publicado: (2020)

An Emergent Form of Cardiotoxicity: Acute Myocarditis Induced by Immune Checkpoint Inhibitors
por: Esposito, Roberta, et al.
Publicado: (2021)

Delayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support
por: Ramayya, Tarun, et al.
Publicado: (2022)

Plasma Exchange for Immune Checkpoint Inhibitor–Induced Myocarditis
por: Yogasundaram, Haran, et al.
Publicado: (2020)

Drug therapy for myocarditis induced by immune checkpoint inhibitors
por: Wu, Yihao, et al.
Publicado: (2023)

Considerations for treatment duration in responders to immune checkpoint inhibitors
por: Marron, Thomas U, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors-Related Myocarditis: A Review of Reported Clinical Cases
por: Zotova, Liudmila
Publicado: (2023)

Immune checkpoint inhibitor–mediated myocarditis and ventricular tachycardia storm
por: McDowall, Lachlan M., et al.
Publicado: (2019)

Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2019)

Biomarkers for Immune Checkpoint Inhibitor–Induced Myocarditis: Caution Needed
por: Jaffe, Allan S.
Publicado: (2022)

Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions
por: Moslehi, Javid, et al.
Publicado: (2022)

Role of mitochondrial metabolism in immune checkpoint inhibitors-related myocarditis
por: Zhang, Xin, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors and Kidney Toxicity: Advances in Diagnosis and Management
por: Seethapathy, Harish, et al.
Publicado: (2021)

Serum Copeptin in Cardiooncology Practice: Review of Pathophysiological and Clinical Implications
por: Yalta, Kenan, et al.
Publicado: (2023)

Value of troponin T versus I in the diagnosis of immune checkpoint inhibitor‐related myocarditis and myositis: rechallenge?
por: Rossi, Valentina A., et al.
Publicado: (2023)

Sinus Node Dysfunction Co-occurring with Immune Checkpoint Inhibitor-associated Myocarditis
por: Nishikawa, Tatsuya, et al.
Publicado: (2022)

Immune checkpoint inhibitor–associated myocarditis: a systematic analysis of case reports
por: Wang, Caie, et al.
Publicado: (2023)

Immunopathogenesis of Immune Checkpoint Inhibitor Induced Myocarditis: Insights from Experimental Models and Treatment Implications
por: Wong, Chun-Ka, et al.
Publicado: (2023)

Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor‐associated myocarditis
por: Xu, Yan, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Induced Myocarditis vs. COVID-19 Vaccine-Induced Myocarditis—Same or Different?
por: Zornitzki, Lior, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kc6nf7juich7r5v0n3gok5norb